GAMMA Investing’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
11,281
+1,225
+12% +$103K 0.04% 395
2026
Q1
$805K Sell
10,056
-327
-3% -$27K 0.04% 409
2025
Q4
$885K Buy
10,383
+532
+5% +$43.7K 0.04% 355
2025
Q3
$766K Buy
9,851
+2,088
+27% +$163K 0.04% 370
2025
Q2
$607K Buy
7,763
+3,059
+65% +$228K 0.04% 412
2025
Q1
$341K Sell
4,704
-57
-1% -$4.08K 0.03% 548
2024
Q4
$352K Buy
4,761
+656
+16% +$45.9K 0.03% 485
2024
Q3
$271K Buy
4,105
+730
+22% +$53K 0.03% 499
2024
Q2
$312K Buy
3,375
+788
+30% +$69.8K 0.04% 383
2024
Q1
$247K Buy
2,587
+292
+13% +$24.5K 0.05% 336
2023
Q4
$180K Buy
+2,295
New +$160K 0.05% 336

Other funds holding EW

GAMMA Investing's EW Position: Q2 2026 in Review

GAMMA Investing increased its Edwards Lifesciences (EW) stake by 12% in Q2 2026, buying an estimated $103K and bringing the position to 11,281 shares worth $1.02M. The position accounts for 0.04% of the portfolio, ranked #395.

GAMMA Investing first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • GAMMA Investing held 11,281 shares of Edwards Lifesciences worth $1.02M as of Q2 2026.
  • GAMMA Investing bought 1,225 Edwards Lifesciences shares in Q2 2026, an estimated $103K.
  • Edwards Lifesciences made up 0.04% of GAMMA Investing's portfolio in Q2 2026, its #395 holding.
  • GAMMA Investing first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • 327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.